Technical Analysis for MNOV - MediciNova, Inc.

Grade Last Price % Change Price Change
grade F 7.75 -1.90% -0.15
MNOV closed down 1.9 percent on Friday, September 20, 2019, on 2.08 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MNOV trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Expansion Breakdown Bearish Swing Setup -1.90%
MACD Bearish Signal Line Cross Bearish -6.40%
Bollinger Band Squeeze Range Contraction -6.40%

Older signals for MNOV ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
MediciNova, Inc., a development stage biopharmaceutical company, focuses on acquiring and developing small molecule therapeutics for the treatment of serious diseases for the United States market. The company's principal product candidates include MN-166, an ibudilast-based drug candidate, which is in Phase I and Phase II clinical trials for the treatment of drug dependence and pain; and MN-221, a ß2 -adrenergic receptor agonist that has completed Phase II clinical trials for the treatment of acute exacerbations of asthma. It also has other product candidates in the clinical development for the treatment of acute exacerbations of asthma, multiple sclerosis and other central nervous system disorders, bronchial asthma, interstitial cystitis, solid tumor cancers, generalized anxiety disorders/insomnia, preterm labor, urinary incontinence, and thrombotic disorders. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.
Medicine Health Pain Medication Multiple Sclerosis Respiratory Therapy Asthma Serious Diseases Central Nervous System Disorders Pulmonology Solid Tumor Cancers Urinary Incontinence Interstitial Cystitis
Is MNOV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 13.37
52 Week Low 6.68
Average Volume 104,005
200-Day Moving Average 9.3744
50-Day Moving Average 8.9648
20-Day Moving Average 8.627
10-Day Moving Average 8.612
Average True Range 0.3264
ADX 18.18
+DI 13.8427
-DI 38.7508
Chandelier Exit (Long, 3 ATRs ) 8.240800000000001
Chandelier Exit (Short, 3 ATRs ) 8.5992
Upper Bollinger Band 9.3295
Lower Bollinger Band 7.9245
Percent B (%b) -0.12
BandWidth 16.286079
MACD Line -0.193
MACD Signal Line -0.0976
MACD Histogram -0.0954
Fundamentals Value
Market Cap 271.78 Million
Num Shares 35.1 Million
EPS -0.29
Price-to-Earnings (P/E) Ratio -26.72
Price-to-Sales 0.00
Price-to-Book 6.66
PEG Ratio -0.91
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.26
Resistance 3 (R3) 8.27 8.12 8.18
Resistance 2 (R2) 8.12 7.99 8.11 8.15
Resistance 1 (R1) 7.93 7.91 7.86 7.92 8.12
Pivot Point 7.78 7.78 7.74 7.77 7.78
Support 1 (S1) 7.59 7.65 7.52 7.58 7.38
Support 2 (S2) 7.44 7.57 7.43 7.35
Support 3 (S3) 7.25 7.44 7.33
Support 4 (S4) 7.24